Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

09. Juin 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3815


	Articles 1 - 20 / 76293

	Combining partial splenic embolization with hepatic artery infusion chemotherapy in the management of chemotherapy-induced hypersplenism in patients with colorectal cancer liver metastases. J Cancer Res Ther Liu B, Gao S, Zheng H, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Wu D, Zhu X. PMID: 42241173 [PubMed - indexed for MEDLINE]
	CEUS features-based nomogram for predicting early recurrence (ER) of microvascular invasion-negative hepatocellular carcinoma. J Cancer Res Ther Shu Q, Liu Y, Pang C, Wang Z, Tian X, Wang S, Yan X, Liang P, Yu J, Yu X. PMID: 42241168 [PubMed - indexed for MEDLINE]
	Thermal ablation versus hepatectomy in patients with liver metastases from RAS-mutated colorectal cancer. J Cancer Res Ther Wen C, Zhou C, Chen S, Shen L, Li C, Fan W. PMID: 42241167 [PubMed - indexed for MEDLINE]
	Advancements in selective internal radiotherapy: Efficacy, safety, and future directions. J Cancer Res Ther Zhang L, Liu L. PMID: 42241154 [PubMed - indexed for MEDLINE]
	Expert consensus on robotic radiosurgery system for hepatocellular carcinoma. J Cancer Res Ther Qiu B, Jiang Y, Lian Z, Xie Y, Wei T, Ji Z, Sun H, Xu F, Peng R, Wang H, Xue J, Li G, Wu G, Wang E, Zhang H, Xu B, Liu S, Duan X, Wang J. PMID: 42241153 [PubMed - indexed for MEDLINE]
	Characteristic Changes in the Immune Landscape of Aging Liver: From Basic Mechanism to Clinical Transformation. J Immunol Res Zhu T, Xu A, Yin W, Li C. PMID: 42237551 [PubMed - indexed for MEDLINE]
	Treatment of hepatic hemangiomas in the era of laparoscopic surgery: Enucleation versus hepatectomy. J Int Med Res Jiang B, Liu J, Yan XF, Xi SH, Fang XS, Wang XM. PMID: 42237069 [PubMed - indexed for MEDLINE]
	Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol. BMJ Open Koroki K, Wakatsuki M, Ogasawara S, Makishima H, Watabe T, Anzai H, Fujiya M, Sawada M, Tsuchiya T, Katayama K, Yoshino R, Izai R, Akatsuka T, Miwa C, Yonemoto T, Yumita S, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Takahashi K, Ozawa Y, Inaba Y, Kurokawa T, Isozaki T, Takahashi A, Kato J, Ohtsuka M, Ohno T, Ueno Y, Furuse J, Kudo M, Hanaoka H, Ishikawa H. PMID: 42229957 [PubMed - indexed for MEDLINE]
	Evaluating Accuracy of LI-RADS Nonradiation Treatment Response Algorithm v2024 and Ancillary Features at Hepatobiliary MRI versus CT. Radiology Shin J, Yoo J, Gu K, Baek SY, Bae JS, Lee MW, Ha SY, Min JH, Lee JM. PMID: 42227857 [PubMed - indexed for MEDLINE]
	Technical complexity and perioperative outcomes of robotic central hepatectomy compared with right and left hepatectomy. J Robot Surg Mascherini J, Vanterpool G Jr, Ross S, Covilo KM, Haripersad O, Eid MK, Sucandy I. PMID: 42223786 [PubMed - indexed for MEDLINE]
	Aflatoxin B1 and food safety: Mechanisms of action associated to Hepatocellular Carcinoma. Arch Microbiol Zamudio MC, Balleza D. PMID: 42223606 [PubMed - indexed for MEDLINE]
	First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and safety. Front Immunol Chen W, Chen B, Hu C, Wei Q, Zhang L, Fu W. PMID: 42220514 [PubMed - indexed for MEDLINE]
	MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma. Front Immunol An X, Gao Y, Zhao S, He W, Yang X, Wu Y, Li J, Yi R, Han Y, Li M, Li Q, Yang T. PMID: 42220486 [PubMed - indexed for MEDLINE]
	Current and Future Landscape of Hepatocellular Carcinoma Treatment. Oncol Res Zerehpoosh S, Tanaka Y, Al-Busafi SA, Aghayeva G, Rouabhia S, Pan Q, Eslam M. PMID: 42220430 [PubMed - indexed for MEDLINE]
	Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma. Liver Int Meischl T, Steurer M, Balcar L, Marcour Y, Meier P, Bucher L, Park YR, Pomej K, Mandorfer M, Reiberger T, Trauner M, Scheiner B, Pinter M. PMID: 42220216 [PubMed - indexed for MEDLINE]
	Excellent Outcomes With High-Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single-Center Experience. Pediatr Transplant Ripa V, Venick RS, Ebaid S, Federman N, Charland N, Thornley CJ, Jou J, Pearson B, Agopian VG, Kaldas FM, McDiarmid SV, Farmer DG. PMID: 42220061 [PubMed - indexed for MEDLINE]
	Foxp3+/CD4+ Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases. Cancer Med Trailin A, Ali E, Pavlov S, Ye W, , Vy, Ambrozkiewicz F, Ji, Daum O, Li, Hemminki K. PMID: 42216261 [PubMed - indexed for MEDLINE]
	Resveratrol's hepatic symphony: conducting a multi-stage intervention in liver cancer's progression. Chin J Nat Med Guo C, Cao F, Zhou L, Guo G, Zheng S, Xia R, Zou Q. PMID: 42215151 [PubMed - indexed for MEDLINE]
	Durable Survival Outcomes After Liver Transplantation for Colorectal Liver Metastases: A Systematic Review and Single-arm Meta-analysis of Prospective Clinical Trials. J Gastrointest Cancer Saqib HW, Siddiq N, Moazzam M, Hamza M, Ahmad M, Omer M, Khan T, Iqbal MF, Murad A, Khan RA, Bhatti ABH. PMID: 42213206 [PubMed - indexed for MEDLINE]
	A study on the correlation between longitudinal inflammatory biomarkers and postoperative prognosis in hepatocellular carcinoma. Biomark Med Guo Y, Deng Y, Jia Y, Cao S, Zhang H. PMID: 42213037 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76293

Page 1 de 3815



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité